Compounds > 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide

2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide and ucn 1028 c

2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide has been researched along with ucn 1028 c in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de la Cruz, A; González, T; Macías, A; Peraza, DA; Prieto, A; Tamkun, MM; Valenzuela, C1

Other Studies

1 other study(ies) available for 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide and ucn 1028 c

ArticleYear
PKC inhibition results in a Kv 1.5 + Kv β1.3 pharmacology closer to Kv 1.5 channels.
    British journal of pharmacology, 2014, Volume: 171, Issue:21

    Topics: HEK293 Cells; Humans; Indoles; Kv1.3 Potassium Channel; Kv1.5 Potassium Channel; Maleimides; Naphthalenes; Protein Kinase C

2014